Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...

The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...

Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

By Stephanie Brown HealthDay ReporterFRIDAY, May 2, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...